focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtalaya Mining Regulatory News (ATYM)

Share Price Information for Atalaya Mining (ATYM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 460.00
Bid: 457.50
Ask: 459.50
Change: 0.00 (0.00%)
Spread: 2.00 (0.437%)
Open: 460.00
High: 460.00
Low: 457.50
Prev. Close: 460.00
ATYM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Files Final Prospectus & Announces Terms of Offer

14 Dec 2010 07:00

RNS Number : 8929X
EMED Mining Public Limited
14 December 2010
 



AIM: EMED 14 December 2010

NOT TO BE DISTRIBUTED TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATED IN THE UNITED STATES

 

EMED Mining Files Final Prospectus and Announces Terms of Offering

 

EMED Mining Public Limited ("EMED Mining" or the "Company") is pleased to announce that it has obtained a receipt for a final prospectus in connection with its previously announced initial public offering in Canada (the "Canadian Offering") of ordinary shares (the "Ordinary Shares"), which final prospectus qualifies the issue of up to 180,970,000 Ordinary Shares at an issue price of CAD$0.135 (approximately 8.5 pence based on an exchange rate of CAD$1.00 = GBP£0.6268) (the "Issue Price") per Ordinary Share for aggregate gross proceeds of up to CAD$24,430,950 (approximately GBP£15,313,320). The Canadian Offering is being made in conjunction with a listing of the Ordinary Shares (the "Listing") on the Toronto Stock Exchange (the "TSX") and is being led by Canaccord Genuity Corp. with a syndicate of agents that includes GMP Securities L.P. and Paradigm Capital Inc. (collectively, the "Canadian Agents"). The Company has also granted the Canadian Agents an option to purchase up to that number of additional Ordinary Shares at the Issue Price as is equal to 15% of the number of Ordinary Shares sold pursuant to the Canadian Offering, exercisable at any time for a period of 30 days from and including the date of the closing of the Canadian Offering (the "Over-allotment Option").

 

Concurrent with the closing of the Canadian Offering, the Company is proposing to complete a private placement of Ordinary Shares, principally in the UK, at an issue price of 8.5 pence (GBP£) (being approximately CAD$0.135) per Ordinary Share (the "UK Offering"). Fox-Davies Capital Limited and Fairfax I.S. plc will act as brokers to the UK Offering. The definitive number of shares to be issued in connection with UK Offering shall be settled based on the number of Ordinary Shares issued in connection with the Canadian Offering. The Company shall not issue greater than an aggregate of 259,241,886Ordinary Shares in connection with the UK Offering and the Canadian Offering and accordingly, the aggregate gross proceeds of the Canadian Offering and the UK Offering will not exceed CAD$35 million (approximately GBP£22 million) (which includes the exercise of the Over-allotment Option).

 

Both the Canadian Offering and the UK Offering are expected to close on or about Monday, December 20, 2010.

 

The Company has received conditional approval for the Listing. The Ordinary Shares will trade on the TSX under the symbol "EMD". The Listing is subject to the Company fulfilling all of the requirements of the TSX, including distribution of the Ordinary Shares to a minimum number of public holders.

 

The pricing of the share offerings represents a discount of 8.3% against the volume weighted average market price of the Company's ordinary shares of 9.27 pence on AIM since the filing of the preliminary prospectus on October 19, 2010.

 

The Ordinary Shares will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any U.S. state securities laws and may not be offered or sold in the United States absent registration or an available exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. No securities commission has approved or disapproved the contents of this press release. 

 

A copy of the final prospectus will be available on SEDAR (www.sedar.com) or by contacting the Company or Canaccord Genuity Corp. at the below numbers.

 

Enquiries

 

EMED Mining

Harry Anagnostaras-Adams

+357 9945 7843

RFC Corporate Finance

Stuart Laing

+61 8 9480 2500

Fox-Davies Capital

Simon Leathers

+44 203 463 5022

Fairfax I.S. PLC

Ewan Leggat/Katy Birkin

+44 207 598 5368

Canaccord Genuity

Craig Warren

+1 416 869 7316

Bishopsgate Communications

Michael Kinirons

+44 207 562 3350

Proconsul Capital

Andreas Curkovic

+1 416 577 9927

 

 

For further information on the Company's activities, visit www.emed-mining.com or www.emed.tv

 

Forward Looking Information

This press release contains "forward-looking information" which may include, but is not limited to, statements with respect to the closing of the Canadian and UK Offering, the future financial or operating performance of the Company, its subsidiaries, future growth, results of operations, performance, business prospects and opportunities. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "believes", or variations (including negative variations) of such words and phrases, or by the use of words or phrases that state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company and/or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements contained in this press release including, without limitation those described in the final prospectus under the heading "Risk Factors". Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in such forward-looking statements, there may be other factors that may cause actions, events or results to differ from those anticipated, estimated or intended. Should one or more of these risks or uncertainties materialize or should assumptions underlying such forward-looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this press release. The forward-looking information and forward-looking statements contained herein are made as of the date of this press release and the company disclaims any obligation to update or review such information or statements, whether as a result of new information, future events or results of otherwise, except as required by law.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMMMZVDNGGZG
Date   Source Headline
26th Apr 20191:30 pmRNSLegal Update
15th Apr 20197:00 amRNSFirst Quarter 2019 Operations Update
4th Apr 20197:00 amRNSResults for the year ended 31 December 2018
29th Mar 20197:00 amRNSLegal Update
15th Jan 20197:00 amRNSOperations Update and 2019 Guidance
22nd Nov 20187:00 amRNS3rd Quarter Results
1st Nov 201812:25 pmRNSResult of Appeal
12th Oct 20184:40 pmRNSSecond Price Monitoring Extn
12th Oct 20184:35 pmRNSPrice Monitoring Extension
12th Oct 20187:00 amRNSRecent press speculation
10th Oct 20187:00 amRNSThird Quarter 2018 Operations Update
26th Sep 20187:00 amRNSReceipt of Ruling of EeA Claim
12th Sep 20187:00 amRNSQ2 and H1 2018 Interim Financial Statements
30th Jul 20187:00 amRNSNI 43-101 Technical Report for Proyecto Riotinto
16th Jul 20187:00 amRNSSecond Quarter 2018 Operations Update
9th Jul 20187:00 amRNSProyecto Riotinto updated 43-101 technical report
27th Jun 201811:41 amRNSResult of AGM
27th Jun 20187:00 amRNSAGM Statement
1st Jun 20181:37 pmRNSIssue of Equity
30th May 20187:00 amRNSNotice of AGM
24th May 20187:00 amRNS1st Quarter Financial Results
21st May 20187:00 amRNSFiling of Pre-Feasibility Study for Proyecto Touro
27th Apr 201810:03 amRNSAudited Financial Statements
23rd Apr 20187:00 amRNSProyecto Touro Pre-feasibility Study
13th Apr 20187:00 amRNSIssue of Equity - Buyout of Rumbo Royalty
11th Apr 20187:00 amRNSFirst quarter 2018 Operations Update
27th Mar 20187:00 amRNSResults for the year ended 31 December 2017
13th Feb 20187:00 amRNSIssue of Equity
22nd Jan 20187:00 amRNS2017 Operations Update and 2018 Guidance
7th Dec 201710:55 amRNSResult of Equity Issue
4th Dec 20177:05 amRNSProposed Placing to raise up to £39 million
4th Dec 20177:01 amRNSApproval of Expansion Project at Proyecto Riotinto
16th Nov 20177:00 amRNS3rd Quarter Financial Results
12th Oct 20177:00 amRNS3rd Quarter Operations Update
7th Sep 20177:00 amRNSHalf-year Report
31st Jul 20177:00 amRNSSecond quarter operations update
13th Jul 20171:05 pmRNSResult of AGM
13th Jul 20179:00 amRNSAGM Statement
15th Jun 20177:00 amRNSNotice of AGM
9th Jun 201712:10 pmRNSDirector/PDMR Shareholding Replacement
9th Jun 201711:20 amRNSDirector/PDMR Shareholding
5th Jun 20177:00 amRNSProyecto Touro - Progress update
2nd Jun 20177:00 amRNSProyecto Riotinto production study to proceed
25th May 20177:00 amRNS1st Quarter Results
20th Apr 20177:00 amRNSFirst Quarter 2017 Operations Update
6th Apr 20177:00 amRNSFinal Results
6th Mar 201711:46 amRNSAstor Management AG case update
2nd Mar 20177:00 amRNSGranting of Share Options
23rd Feb 20177:00 amRNSOption to acquire Touro Copper Project interest
3rd Feb 20177:00 amRNSAstor Management AG litigation case update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.